Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 142 clinical trials for: 150 miles

Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
  • Recruiting
NCT06989437
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
  • Recruiting
NCT07729462
Sex: All
Age: 18+
Locations: 21
View study
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
  • Recruiting
NCT07028853
Sex: Male
Age: 18+
Locations: 50
View study
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
  • Recruiting
NCT05156398
Sex: All
Age: 6 - 17
Locations: 50
View study
Recruiting
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
  • Recruiting
NCT07609914
Sex: All
Age: 18+
Locations: 24
View study
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
  • Recruiting
NCT07013474
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
  • Recruiting
NCT06866405
Sex: All
Age: 0+
Locations: 50
View study
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  • Recruiting
NCT06629779
Sex: Male
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults
  • Recruiting
NCT07768345
Sex: All
Age: 18+
Locations: 17
View study
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
  • Recruiting
NCT06952660
Sex: Female
Age: 18+
Locations: 69
View study
...